Iris Wang - Partner @ OrbiMed - Crunchbase Person Profile

Overview

CB Rank (Investor)

Iris Wang is the Partner at OrbiMed.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Dingdang Kuaiyao	OrbiMed	Yes	Private Equity Round - Dingdang Kuaiyao	obfuscated obfuscation
obfuscated obfuscation	EDDA Technology	OrbiMed	—	Private Equity Round - EDDA Technology	obfuscated obfuscation
obfuscated obfuscation	LakeShore Biopharma	OrbiMed	Yes	Series B - LakeShore Biopharma	obfuscated obfuscation
obfuscated obfuscation	Harbour Biomed	OrbiMed	—	Series C - Harbour Biomed	obfuscated obfuscation
obfuscated obfuscation	Akeso Biopharma	OrbiMed	—	Series D - Akeso Biopharma	obfuscated obfuscation
obfuscated obfuscation	Alphamab Oncology	OrbiMed	—	Series A - Alphamab Oncology	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

Partner

. Additionally,

has had

past job as the

Director, Public Equity, Asia

Organization Name	Title At Company	Start Date	End Date
OrbiMed	Director, Public Equity, Asia	Sep 2017	—

Hub Name	CB Rank (Hub)
Seed Stage Investors with Investments in Hong Kong	10,490
Post IPO Investors with Investments in Asia	11,813
Investors Active in Hong Kong	5,175
Private Equity Firms with Investments in Hong Kong	28,984
Private Equity Firms with Investments in Asia	6,703
Venture Stage Investors with Investments in Hong Kong	19,757
Private Equity Stage Investors with Investments in Hong Kong	33,824
Post IPO Investors with Investments in Asia-Pacific (APAC)	10,228
Early Stage Venture Investors with Investments in Hong Kong	7,258
Private Equity Firms with Investments in Asia-Pacific (APAC)	7,253

There is no recent news or activity for this profile.